http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103450342-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-02 |
| filingDate | 2012-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103450342-B |
| titleOfInvention | Tetrahydroisoquinoline-3-carboxylic acid modify PARGD seven peptide, its synthesis, antithrombotic acitivity and application |
| abstract | The 3 kinds of novel antithrombotics that the invention provides general formula I representative intend peptide, provide their molecule simulation method, provide their preparation method, provide the restraining effect that they express glycoprotein iib/iiia and palatelet-selectin, provide their antiplatelet aggregative activity, further provide their anti thrombotic actions on rat suppository formation model.Thus the 3 kinds of antithrombotics that the invention provides general formula I representative intend the potential applicability in clinical practice of peptide as antithrombotic agent.In formula, AA represents Ser or Val or Phe residue. |
| priorityDate | 2012-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 86.